Delia Calo
Overview
Explore the profile of Delia Calo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
69
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mendelsohn R, Hahn A, Palmaira R, Saxena A, Mukthinuthalapati P, Schattner M, et al.
Clin Gastroenterol Hepatol
. 2024 May;
22(12):2517-2525.e3.
PMID: 38729386
Background & Aims: Early-onset colorectal cancer (EO-CRC), diagnosed before age 50, is rising in incidence worldwide. Although post-surgical colonoscopy surveillance strategies exist, appropriate intervals in EO-CRC remain elusive, as long-term...
2.
Ceravolo A, Yang J, Latham A, Markowitz A, Shia J, Mermelstein J, et al.
Int J Colorectal Dis
. 2021 Oct;
37(1):231-238.
PMID: 34698909
Background And Aims: Lynch syndrome (LS) is the most common cause of hereditary colorectal cancer and is associated with an increased lifetime risk of gastric and duodenal cancers of 8-16%...
3.
Elmunzer B, Spitzer R, Foster L, Merchant A, Howard E, Patel V, et al.
Clin Gastroenterol Hepatol
. 2020 Oct;
19(7):1355-1365.e4.
PMID: 33010411
Background & Aims: The prevalence and significance of digestive manifestations in coronavirus disease 2019 (COVID-19) remain uncertain. We aimed to assess the prevalence, spectrum, severity, and significance of digestive manifestations...
4.
Mendelsohn R, DeLeon S, Calo D, Villegas S, Carlesimo M, Wang J, et al.
J Racial Ethn Health Disparities
. 2020 Jul;
8(3):559-565.
PMID: 32643126
Introduction: Disparities observed in colorectal cancer (CRC) incidence and mortality among blacks and Hispanics compared with whites may be in part due to lower screening rates. The New York City...
5.
Dibba P, Ludwig E, Calo D, Gerdes H, Markowitz A, Shike M, et al.
Surg Endosc
. 2020 Jun;
35(6):2976-2980.
PMID: 32583069
Introduction: Bevacizumab is a humanized anti-vascular endothelial growth factor monoclonal antibody used in the treatment of cervical cancer, ovarian cancer, colorectal cancer, lung cancer, renal cell cancer, and recurrent glioblastomas....
6.
Sethi A, Swaminath A, Latorre M, Behin D, Jodorkovsky D, Calo D, et al.
Clin Gastroenterol Hepatol
. 2020 Apr;
18(8):1673-1681.
PMID: 32330565
The COVID-19 pandemic seemingly is peaking now in New York City and has triggered significant changes to the standard management of gastrointestinal diseases. Priorities such as minimizing viral transmission, preserving...